Institutional investors control 20.88% of the outstanding shares in RPRX. This represents a greater percentage of ownership than at almost any other company in the Medical Specialties industry. Additionally, during the quarter ended June 2017, these large investors purchased a net $1.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ROSALIND ADVISORS, INC. Bought 2.1 Million shares of Repros Therapeutics Inc